Andrew Yule [ANDREWYU] vs Dhampur Bio Organics [DBOL] Detailed Stock Comparison

Andrew Yule
BSE
Loading...

Dhampur Bio Organics
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Andrew Yule wins in 7 metrics, Dhampur Bio Organics wins in 11 metrics, with 0 ties. Dhampur Bio Organics appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Andrew Yule | Dhampur Bio Organics | Better |
---|---|---|---|
P/E Ratio (TTM) | 97.44 | 37.87 | Dhampur Bio Organics |
Price-to-Book Ratio | 5.16 | 0.52 | Dhampur Bio Organics |
Debt-to-Equity Ratio | 31.10 | 114.89 | Andrew Yule |
PEG Ratio | -1.04 | -0.55 | Andrew Yule |
EV/EBITDA | -22.99 | 16.48 | Andrew Yule |
Profit Margin (TTM) | -0.91% | -0.38% | Dhampur Bio Organics |
Operating Margin (TTM) | -60.30% | -2.08% | Dhampur Bio Organics |
Return on Equity | -0.84% | 1.45% | Dhampur Bio Organics |
Return on Assets (TTM) | -7.31% | 0.61% | Dhampur Bio Organics |
Free Cash Flow (TTM) | $-235.61M | $-161.70M | Dhampur Bio Organics |
Dividend Yield | N/A | 1.50% | N/A |
1-Year Return | -53.15% | -40.40% | Dhampur Bio Organics |
Price-to-Sales Ratio (TTM) | 4.53 | 0.27 | Dhampur Bio Organics |
Enterprise Value | $18.15B | $16.57B | Andrew Yule |
EV/Revenue Ratio | 5.82 | 0.85 | Dhampur Bio Organics |
Gross Profit Margin (TTM) | 24.93% | 15.25% | Andrew Yule |
Revenue per Share (TTM) | $7 | $285 | Dhampur Bio Organics |
Earnings per Share (Diluted) | $-0.06 | $-1.12 | Andrew Yule |
Beta (Stock Volatility) | 0.66 | 0.89 | Andrew Yule |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Andrew Yule vs Dhampur Bio Organics Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Andrew Yule | -0.03% | -1.53% | -9.10% | 4.87% | -25.01% | -26.40% |
Dhampur Bio Organics | -0.01% | -10.23% | -5.09% | 10.59% | -12.14% | -30.99% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Andrew Yule | -53.15% | 34.01% | 101.68% | -1.60% | -31.97% | -15.06% |
Dhampur Bio Organics | -40.40% | -51.88% | -51.88% | -51.88% | -51.88% | -51.88% |
Performance & Financial Health Analysis: Andrew Yule vs Dhampur Bio Organics
Metric | ANDREWYU | DBOL |
---|---|---|
Market Information | ||
Market Cap | ₹14.12B | ₹5.27B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 99,238 | 137,521 |
90 Day Avg. Volume | 87,601 | 112,513 |
Last Close | ₹28.87 | ₹79.36 |
52 Week Range | ₹22.65 - ₹59.75 | ₹57.34 - ₹163.93 |
% from 52W High | -51.68% | -51.59% |
All-Time High | ₹99.70 (Jan 18, 2010) | ₹229.00 (Dec 19, 2022) |
% from All-Time High | -71.04% | -65.34% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.29% | 0.17% |
Quarterly Earnings Growth | 0.32% | 0.13% |
Financial Health | ||
Profit Margin (TTM) | -0.01% | 0.00% |
Operating Margin (TTM) | -0.60% | -0.02% |
Return on Equity (TTM) | -0.01% | 0.01% |
Debt to Equity (MRQ) | 31.10 | 114.89 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹5.60 | ₹152.40 |
Cash per Share (MRQ) | ₹0.64 | ₹4.93 |
Operating Cash Flow (TTM) | ₹-110,484,000 | ₹1.09B |
Levered Free Cash Flow (TTM) | ₹2.22M | ₹146.90M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 1.50% |
Last 12-Month Dividend | ₹0.00 | ₹1.25 |
Valuation & Enterprise Metrics Analysis: Andrew Yule vs Dhampur Bio Organics
Metric | ANDREWYU | DBOL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 97.44 | 37.87 |
Forward P/E | N/A | N/A |
PEG Ratio | -1.04 | -0.55 |
Price to Sales (TTM) | 4.53 | 0.27 |
Price to Book (MRQ) | 5.16 | 0.52 |
Market Capitalization | ||
Market Capitalization | ₹14.12B | ₹5.27B |
Enterprise Value | ₹18.15B | ₹16.57B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.82 | 0.85 |
Enterprise to EBITDA | -22.99 | 16.48 |
Risk & Other Metrics | ||
Beta | 0.66 | 0.89 |
Book Value per Share (MRQ) | ₹5.60 | ₹152.40 |
Financial Statements Comparison: Andrew Yule vs Dhampur Bio Organics
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ANDREWYU | DBOL |
---|---|---|
Revenue/Sales | ₹975.11M | ₹5.26B |
Cost of Goods Sold | ₹731.98M | ₹4.45B |
Gross Profit | ₹243.12M | ₹801.50M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹-593.57M | ₹-129.00M |
EBITDA | ₹-58.66M | ₹29.60M |
Pre-Tax Income | ₹-155.12M | ₹-329.60M |
Income Tax | ₹-27.89M | ₹-109.60M |
Net Income (Profit) | ₹-6.06M | ₹-220.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ANDREWYU | DBOL |
---|---|---|
Cash & Equivalents | ₹73.02M | ₹88.80M |
Total Current Assets | ₹2.43B | ₹12.29B |
Total Current Liabilities | ₹3.63B | ₹10.82B |
Long-Term Debt | ₹15.32M | ₹2.42B |
Total Shareholders Equity | ₹3.39B | ₹10.12B |
Retained Earnings | N/A | ₹2.34B |
Property, Plant & Equipment | ₹1.92B | ₹120.40M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ANDREWYU | DBOL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ANDREWYU | DBOL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 99,238 | 137,521 |
Average Daily Volume (90 Day) | 87,601 | 112,513 |
Shares Outstanding | 488.95M | 66.39M |
Float Shares | 59.58M | 22.85M |
% Held by Insiders | 0.91% | 0.66% |
% Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Andrew Yule vs Dhampur Bio Organics
Metric | ANDREWYU | DBOL |
---|---|---|
Last 12-Month Dividend | ₹0.00 | ₹1.25 |
Last 12-Month Dividend Yield | N/A | 1.50% |
3-Year Avg Annual Dividend | ₹0.00 | ₹2.42 |
3-Year Avg Dividend Yield | 0.03% | 1.77% |
3-Year Total Dividends | ₹0.01 | ₹7.25 |
Ex-Dividend Date | Aug 24, 2023 | Jul 04, 2025 |